Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma [8]

1. Van De Donk, N.W.C.J.
2. Kröger, N.
3. Hegenbart, U.
4. Corradini, P.
5. San Miguel, J.F.
6. Goldschmidt, H.
7. Perez-Simon, J.A.
8. Zijlmans, M.
9. Raymakers, R.A.
10. Montefusco, V.
11. Ayuk, F.A.
12. Van Oers, M.H.J.
13. Nagler, A.
14. Verdonck, L.F.
15. Lokhorst, H.M.